bpc 157 peptide liposomal BPC-157 Therapy Introducing: Liposomal BPC-157 + TB-500

PubMed 22962027 TB-4 Phase 1 human safety first-in-human randomized, double-blind, single- and multiple-dose Phase 1 of recombinant human thymosin 4 in healthy volunteers, no serious adverse events: PubMed 34346165

More energy

Not intended for human or animal consumption or ingestion

We only recommend products and services that we genuinely believe in and that align with our commitment to promoting holistic health

BPC-157 has shown a strong safety profile in both animal and early human studies

Additionally, it has been shown that BPC 157, even with a single administration, managed to control right heart failure, increased P wave amplitude, tachycardia, and ST elevation caused by acute thrombotic coronary occlusion in mice (6, 7, 8)